Three signals aligned on BWIN this week — and they all point in the same direction. Short sellers are exiting fast, options traders are skewing heavily bullish, and one analyst is worried enough to step to the sidelines. The disconnect makes Baldwin Insurance one of the more interesting reads in the insurance brokerage space right now.
The headline number is hard to ignore. Short interest in BWIN dropped 26% in a single week, falling from roughly 12.0% of free float to 12.4% — still elevated, but moving fast in one direction. At the daily level, shares short fell another 17% on September 17 alone. Over the past month, short interest is down 22%.
Availability tells the same story. One week ago, availability sat at around 119%. Today it has surged to 304% — more than three shares available to borrow for every one already lent out. The borrow market has opened up dramatically. The cost to borrow has barely moved, sitting at just 0.52%, confirming this isn't a forced squeeze. Short sellers are choosing to cover.
Options traders have simultaneously piled into calls. The put-call ratio stood at 0.10 on September 17 — near a 52-week low of 0.058, and well below the 20-day mean of 0.154. That's roughly one put bought for every ten calls. The z-score is -1.55 standard deviations below the mean. This level of call dominance has been sustained across multiple sessions now, not a one-day spike.
The ORTEX short score has also moved sharply. It stood at 74.1 on September 7. By September 17 it had dropped to 58.1. A falling short score reflects easing short-side pressure. That 16-point move in ten days is the fastest unwind the score has logged in recent months.
William Blair's Adam Klauber downgraded BWIN to Market Perform from Outperform on September 14, citing elevated leverage and macro headwinds. The next day, BMO Capital's Charlie Lederer held his Market Perform rating but lifted his price target sharply — from $26 to $32.50. The consensus sits at "Hold" with a mean target of $32.93, roughly in line with the current price of $31.95.
The William Blair downgrade carries an extra note of context: William Blair Investment Management holds approximately 7% of BWIN's shares as last disclosed, making it one of the largest institutional holders on the register. The investment management arm and the research arm operate independently, but the timing is worth noting.
Data summary
See the live data behind this article on ORTEX.
Open BWIN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
